Kamal Medicos Pharma

Soliris 300mg Injection contains the active ingredient Eculizumab. it is a medication that works by inhibiting the complement protein C5 in the immune system. It is primarily used to treat rare blood disorders such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalised myasthenia gravis (gMG). The benefits of this medication include preventing the destruction of red blood cells, reducing the risk of blood clots, improving kidney function, and helping manage muscle weakness associated with autoimmune conditions.
Soliris Injection is also prescribed in conditions where uncontrolled complement activation can cause organ damage. The complement system is a part of the immune system that normally protects the body from infections, but can attack healthy cells when overactive.
The Soliris Injection price varies depending on dosage and pack size. Patients should consult their doctor or pharmacist for the exact cost. Always purchase from verified pharmacies to ensure safety, authenticity, and proper storage of the medication.
Uses
Soliris 300mg Injection is approved for the following conditions:
Paroxysmal Nocturnal Hemoglobinuria (PNH): Prevents destruction of red blood cells and reduces anaemia and risk of blood clots.
Atypical Hemolytic Uremic Syndrome (aHUS): Helps protect kidneys and prevents organ damage caused by uncontrolled complement activation.
Generalised Myasthenia Gravis (gMG): Reduces muscle weakness and improves daily functioning in patients with antibodies against acetylcholine receptors.
Prevention of Complement-Mediated Organ Damage: Used in conditions where overactivation of the complement system can harm organs.
Other Rare Complement-Mediated Disorders: May be prescribed for other conditions as determined by a physician.
How Soliris 300mg Injection works
Soliris 300mg Injection is a medicine that works by blocking a specific protein called C5 in the immune system. Normally, this protein helps the body fight infections. However, in certain diseases, it can target healthy red blood cells and organs, leading to severe complications.
In conditions like paroxysmal nocturnal hemoglobinuria (PNH), Soliris 300mg Injection prevents the destruction of red blood cells, reducing anaemia and the risk of blood clots. In atypical hemolytic uremic syndrome (aHUS), it protects the kidneys and other organs from damage caused by an overactive immune system.
For people with generalised myasthenia gravis (gMG), Soliris 300mg Injection reduces the immune system’s attack on nerves and muscles, helping improve muscle strength and daily functioning.

Alburel 20gm Solution for Infusion is used to treat blood volume loss. It works by replacing the body fluids lost due to excessive trauma, bleeding, surgery, or kidney dialysis. Thus, it is helpful in treating low blood albumin levels.
Uses of Alburel Injection
Short term fluid replacement after trauma
Benefits of Alburel Injection
Short term fluid replacement after trauma
Alburel 20gm Solution for Infusion is used in short-term fluid replacement after trauma to help restore blood volume and maintain circulation. It supports stable blood pressure and improves oxygen delivery to vital organs during recovery.

Osimert 80mg Tablet is a protein kinase inhibitor used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain estimated glomerular filtration rate (EGFR) mutations.
Osimertinib is an anticancer medication that the Food and Drug Administration approved on the 18th of April 2018 as a first-line treatment for patients having non-small cell lung cancer (NSLC), that has spread to other parts and whose tumors have epidermal growth factor receptor (EGFR) mutations.

Tagrisso 80mg Tablet is primarily used to help prevent a certain type of non-small-cell lung cancer (NSCLC) from returning after the tumour has been removed by surgery. It belongs to the class of medications called kinase inhibitors.
It is also used alone and in combination with other chemotherapy medications as a first treatment for a certain type of NSCLC that has spread to nearby tissues or to other parts of the body in adults. Osimertinib is also used to treat certain types of NSCLC that have spread to other parts of the body in adults who could not be treated successfully with other similar chemotherapy medications.
Uses of Tagrisso 80mg Tablet 10
Tagrisso 80mg Tablet is used for the following:
Metastatic NSCLC: Treats patients with EGFR T790M mutation-positive non-small cell lung cancer (NSCLC).
Targeted Therapy: Provides an advanced line of treatment for NSCLC patients resistant to first- and second-generation EGFR tyrosine kinase inhibitors.
How Tagrisso 80mg Tablet 10 Works?
Tagrisso 80mg Tablet contains osimertinib (80 mg). Here's how it works:
Osimertinib is a third-generation tyrosine kinase inhibitor that selectively targets both EGFR-sensitising and T790M resistance mutations. It blocks the signals that stimulate cancer cell growth and survival, leading to tumour regression and improving the patient's condition.

Letroheal-2.5 Tablet is primarily used to manage certain types of breast cancer in women who have ceased menstruation. This medicine forms part of a group known as aromatase inhibitors.

In addition to its main use, Letroheal is also prescribed for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It's used as an extended adjuvant treatment in early breast cancer cases where women have previously received standard adjuvant tamoxifen therapy. Moreover, it serves as a first-line and second-line tool for managing hormone receptor-positive or unknown advanced breast cancer in postmenopausal women

How Letrozole works
Letrozole is an aromatase inhibitor.

It works by blocking the action of an enzyme called aromatase, which is responsible for converting androgens (a type of hormone) into oestrogens. In specific types of breast cancer, oestrogens can encourage the tumour to grow. Therefore, by reducing the production of oestrogens, Letrozole helps slow down or halt the growth of these cancer cells.

It works by inhibiting the tyrosine kinases, thus preventing the activation of downstream signalling pathways that are involved in cell proliferation, survival, and differentiation. This leads to the inhibition of cancer cell growth and survival.
This tablet contains lactose as an inactive ingredient, which the body is unable to digest. Lactose is a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy.

Selinexor 20 mg Tablet is an oral anticancer medication used in the treatment of certain blood cancers, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL) that have relapsed or not responded to previous therapies. The tablet contains Selinexor, a first-in-class selective inhibitor of nuclear export (SINE) that works by targeting the XPO1 (exportin-1) protein involved in cancer cell growth and survival.

Tagrisso 80mg tablet contains the active substance Osimertinib. It is an antineoplastic drug that belongs to the class protein kinase inhibitor. tagrisso used to treat adults with a type of lung cancer called non-small cell lung cancer. If a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor), then your cancer will likely respond to treatment with this medicine.

Tagrisso 80mg tablet can be given to you after the complete removal of your cancer as a post-surgical adjuvant treatment. It can also be given as the first-line medication for cancer that has spread to other body parts. It is also used to treat certain types of  NSCLC that have spread to other body parts in adults who could not be treated successfully with similar chemotherapy medications. 

Venetoclax Film-Coated Tablets 100 mg
Venetoclax 100 mg Film-Coated Tablets are a targeted oral anticancer medication used primarily in the treatment of certain blood cancers. Venetoclax is a selective BCL-2 inhibitor that helps restore the natural process of programmed cell death (apoptosis) in cancer cells, thereby reducing tumor growth and disease progression.
This medicine is commonly prescribed for Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and in combination therapies for Acute Myeloid Leukemia (AML), as per medical guidelines. The tablets are film-coated for easy swallowing and improved patient compliance.
Each pack contains 28 film-coated tablets of 100 mg strength, intended for oral use only. The product is manufactured under strict quality standards and is supplied in secure blister packaging to ensure stability and protection.
Key Features:
Active ingredient: Venetoclax
Strength: 100 mg
Dosage form: Film-coated tablet
Pack size: 28 tablets
Route of administration: Oral
Indication: CLL, SLL, AML (as prescribed)
Storage: Store below 30C, protected from moisture and light.

Alkixen (Crizotinib) Capsules 250 mg is a prescription anti-cancer medicine used for the treatment of ALK and ROS1 positive non-small cell lung cancer (NSCLC). Each capsule contains Crizotinib INN 250 mg and is supplied in a pack of 60 capsules for oral use. Manufactured by Everest Pharmaceuticals Ltd. Quality assured, and suitable for oncology hospitals, distributors, and pharmaceutical traders.

Tucaxen 150 (Tucatinib) Tablets is a targeted oncology medicine containing Tucatinib INN 150 mg, a selective HER2 tyrosine kinase inhibitor that blocks HER2 signaling pathways responsible for cancer cell growth. It is primarily used in the treatment of HER2-positive breast cancer, including advanced or metastatic cases, as prescribed by an oncologist. Each pack contains 30 film-coated tablets for oral administration. Manufactured by Everest Pharmaceuticals Ltd., this product complies with international quality standards and is suitable for oncology hospitals, pharmaceutical distributors, and exporters.

Zelboraf (Vemurafenib) 240 mg Tablets is an innovator targeted oncology medicine manufactured by Roche. It contains Vemurafenib 240 mg, a selective BRAF inhibitor used for the treatment of unresectable or metastatic melanoma in patients whose tumors test positive for the BRAF V600 mutation (V600E or V600K).
Vemurafenib works by blocking the abnormal BRAF protein that promotes uncontrolled cancer cell growth, thereby slowing disease progression and improving clinical outcomes. Zelboraf is supplied as film-coated tablets for oral administration and is prescribed strictly under the supervision of an oncologist after confirmed BRAF mutation testing.

Vorasidenib Tablet (brand name: Voranigo) is an advanced oral anti-cancer medication used for the treatment of specific types of brain tumors, including astrocytoma and oligodendroglioma associated with IDH1 or IDH2 mutations. It belongs to the class of targeted therapies known as IDH inhibitors, designed to slow down tumor growth by blocking abnormal enzymes responsible for cancer cell development.

Key Features
Form: Oral Tablet
Drug Class: Antineoplastic / Targeted Therapy (IDH1 & IDH2 Inhibitor)
Indication: Brain Cancer (Glioma – Astrocytoma & Oligodendroglioma)
Dosage: As prescribed by oncologist
Usage: Hospital / Clinical / B2B Supply